报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 34.69% | -6.58% | -2.58% | 102/129 | 53.43% | 佰仁医疗 | 88.56% | 行业排名> |
2024-06-30 | 35.61% | 0.4% | 10.08% | 100/129 | 53.65% | 佰仁医疗 | 89.27% | 行业排名> |
2024-03-31 | 32.35% | -1.16% | -24.78% | 100/129 | 53.62% | 佰仁医疗 | 89.28% | 行业排名> |
2023-12-31 | 43.01% | -15.32% | 15.82% | 86/129 | 53.85% | 正海生物 | 89.9% | 行业排名> |
2023-09-30 | 37.14% | -33.15% | 4.7% | 94/129 | 54.06% | 正海生物 | 90.39% | 行业排名> |
2023-06-30 | 35.47% | -38.26% | 8.36% | 97/129 | 53.61% | 正海生物 | 90.3% | 行业排名> |
2023-03-31 | 32.73% | -48.51% | -35.56% | 102/129 | 53.66% | 正海生物 | 89.78% | 行业排名> |
2022-12-31 | 50.79% | -31.16% | -8.56% | 76/129 | 54.04% | 三友医疗 | 90.18% | 行业排名> |
2022-09-30 | 55.55% | -27.87% | -3.29% | 65/129 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
2022-06-30 | 57.44% | -26.88% | -9.65% | 64/129 | 54.78% | 三友医疗 | 90.29% | 行业排名> |
2022-03-31 | 63.57% | -15.59% | -13.84% | 49/129 | 56.28% | 三友医疗 | 90.73% | 行业排名> |
2021-12-31 | 73.79% | -6.88% | -4.19% | 24/129 | 57.38% | 三友医疗 | 90.5% | 行业排名> |
2021-09-30 | 77.01% | -7.25% | -1.97% | 16/129 | 59.17% | 三友医疗 | 90.29% | 行业排名> |
2021-06-30 | 78.56% | -5.09% | 4.3% | 16/129 | 58.42% | 正海生物 | 90.78% | 行业排名> |
2021-03-31 | 75.32% | 19.09% | -4.95% | 20/129 | 60.75% | 正海生物 | 91.59% | 行业排名> |
2020-12-31 | 79.24% | 66.81% | -4.57% | 17/129 | 59.67% | 正海生物 | 92.23% | 行业排名> |
2020-09-30 | 83.03% | 76.65% | 0.31% | 10/129 | 61.59% | 正海生物 | 92.69% | 行业排名> |
2020-06-30 | 82.77% | 76.84% | 30.88% | 13/129 | 59.94% | 正海生物 | 92.61% | 行业排名> |
2020-03-31 | 63.24% | 2% | 33.13% | 34/129 | 58.33% | 正海生物 | 94.38% | 行业排名> |
2019-12-31 | 47.51% | -2.39% | 1.06% | 75/129 | 56.37% | 正海生物 | 93.12% | 行业排名> |
2019-09-30 | 47.01% | 2% | 0.42% | 38/129 | 55.22% | 正海生物 | 93.78% | 行业排名> |
2019-06-30 | 46.81% | 2% | -3.83% | 47/129 | 57.37% | 正海生物 | 93.09% | 行业排名> |
2018-12-31 | 48.67% | 1.14% | 1.14% | 65/129 | 55.53% | 正海生物 | 93.85% | 行业排名> |
2017-12-31 | 48.12% | 2% | 2% | 62/129 | 55.34% | 正海生物 | 93.08% | 行业排名> |